ALPS Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Sell |
24,429
-8,880
| -27% | -$40K | ﹤0.01% | 1024 |
|
|
2025
Q1 | $148K | Sell |
33,309
-2,906
| -8% | -$12.9K | ﹤0.01% | 972 |
|
|
2024
Q4 | $284K | Buy |
36,215
+1,984
| +6% | +$15.5K | ﹤0.01% | 927 |
|
|
2024
Q3 | $450K | Buy |
34,231
+7
| +0% | +$92 | ﹤0.01% | 623 |
|
|
2024
Q2 | $413K | Buy |
+34,224
| New | +$413K | ﹤0.01% | 627 |
|
|
2022
Q1 | – | Sell |
-50,503
| Closed | -$819K | – | 1014 |
|
|
2021
Q4 | $819K | Sell |
50,503
-2,906
| -5% | -$47.1K | 0.01% | 386 |
|
|
2021
Q3 | $1.52M | Sell |
53,409
-3,977
| -7% | -$113K | 0.01% | 347 |
|
|
2021
Q2 | $1.94M | Buy |
+57,386
| New | +$1.94M | 0.02% | 331 |
|
|
2020
Q4 | – | Sell |
-51,029
| Closed | -$1.96M | – | 885 |
|
|
2020
Q3 | $1.96M | Sell |
51,029
-3,210
| -6% | -$123K | 0.03% | 238 |
|
|
2020
Q2 | $2.34M | Buy |
+54,239
| New | +$2.34M | 0.03% | 224 |
|
|
2019
Q4 | – | Sell |
-68,175
| Closed | -$1.78M | – | 864 |
|
|
2019
Q3 | $1.78M | Sell |
68,175
-3,400
| -5% | -$88.6K | 0.01% | 222 |
|
|
2019
Q2 | $1.64M | Buy |
+71,575
| New | +$1.64M | 0.01% | 254 |
|